- Original Article
-
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
-
Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Kwong Ming Fock, Ngai Moh Law, Sin-Yoong Chong, Fria Gloriba Manejero, Tiing-Leong Ang, Eng Kiong Teo, Jessica Tan
-
Clin Mol Hepatol. 2021;27(3):474-485. Published online February 19, 2021
-
-
-
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
-
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu
-
Clin Mol Hepatol. 2021;27(1):186-196. Published online December 3, 2020
-
-
-
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
-
Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
-
Clin Mol Hepatol. 2021;27(1):125-135. Published online November 27, 2020
-
-
- Original Article
-
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
-
Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
-
Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019
-
-
-
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
-
Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang
-
Clin Mol Hepatol. 2019;25(4):400-407. Published online May 28, 2019
-
-
-
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
-
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
-
Clin Mol Hepatol. 2019;25(1):42-51. Published online November 19, 2018
-
-
-
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
-
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
-
Clin Mol Hepatol. 2017;23(1):51-56. Published online March 16, 2017
-
-
- 4
-
Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C
-
Yun Nah Lee, M.D., Soung Won Jeong, M.D., Jae Hee Lim, M.D., Yang Seon Ryu, M.D.,
Seong Ran Jeon, M.D., Sang Kyun Kim, M.D., Jae Young Jang, M.D.,
Young Seok Kim, M.D., Boo Sung Kim, M.D., Mi Oh Roh, M.D.
-
Clin Mol Hepatol. 2010;16(2):187-191. Published online June 25, 2010
-
-
- 3
-
Clinical Significance of Intrahepatic HCV RNA Level in Chronic HCV Infection
-
Jae Young Jang, M.D., Yun Soo Kim, M.D. Sang Gyune Kim, M.D., Young Seok Kim, M.D.,
Young Deok Cho, M.D., Joon Sung Lee, M.D., So Young Jin, M.D. Moon Sung Lee, M.D.,
Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.
-
Clin Mol Hepatol. 2006;12(4):515-523. Published online January 1, 1970
-
-
View: 2634
Download: 22
|